| WALTHAM, Mass., Nov. 10, 2011 /PRNewswire/ -- Interleukin Genetics, Inc. (OTCQB: ILIU) today announced financial and operational results for the third quarter ended September 30, 2011. Total revenue for the three months ended September 30, 2011 was $765,000, compared to $545,000 for the same period in the prior year. The increase was attributable to greater genetic test revenue. Research and development expenses were $325,000 for the three months ended September 30, 2011, compared to $317,000 for t...continued ILIU |
Thursday, November 10, 2011
Interleukin Genetics Reports Third Quarter 2011 Financial Results
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment